Eminence Capital’s Darling Ingredients DAR Stock Holding History

Eminence Capital’s Portfolio DAR Stock Details DAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,245,000	Closed	-$87.5M	–	63
2015 Q1	$87.5M	Sell	6,245,000 -2,017,343	-24%	-$33.2M	1.35%	41
2014 Q4	$150M	Buy	+8,262,343	New	+$149M	2.18%	13

Other funds holding DAR

SAM

Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Eminence Capital's DAR Position: Q2 2015 in Review

Eminence Capital sold out of Darling Ingredients (DAR) in Q2 2015, closing a stake of 6,245,000 shares — an estimated $87.5M sold.

Eminence Capital first reported a position in DAR in Q4 2014 and held it in 2 quarters. The position peaked at $150M in Q4 2014. 253 funds tracked by Wall St. Rank hold DAR as of Q2 2015.

Eminence Capital reported no remaining Darling Ingredients position as of Q2 2015 after selling out during the quarter.
Eminence Capital sold 6,245,000 Darling Ingredients shares in Q2 2015, an estimated $87.5M.
Eminence Capital first reported a position in Darling Ingredients in Q4 2014 and held it in 2 quarters.
Eminence Capital's Darling Ingredients position peaked at $150M in Q4 2014.
253 funds tracked by Wall St. Rank held Darling Ingredients as of Q2 2015.

Based on Eminence Capital's 13F filing for Q2 2015, filed 14 Aug 2015.